Enlaza Therapeutics
Covalent biologic platform for site-specific protein coupling in cancer therapeutics
- Sector
- Biotech
- Founded
- 2020
- Latest Form D
- $15M, Sep 2025
- Total capital
- $103M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $103M
- 7 Form D · last Sep 2025
- 14 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 10 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$15M
- Private capital raisedForm D · SEC · 3rd filing$84M
- Offering registeredForm D · SEC · 2nd filing$312K
- Private capital raisedForm D · SEC · 1st filing$4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
3 records have no date or no amount, so they aren’t placed on the timeline.
Founders and team
From SEC Form D filings- James TopperDirectorNamed in SEC Form D filings
- Jay LichterDirectorNamed in SEC Form D filings
- Marcos MillaDirectorNamed in SEC Form D filings
- Sanford MadiganExecutive OfficerNamed in SEC Form D filings
- Sergio DuronExecutive Officer, DirectorNamed in SEC Form D filings
- Shelley ChuDirectorNamed in SEC Form D filings
Show all 8 people
- Stephen SquintoDirectorNamed in SEC Form D filings
- Tighe ReardonExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 10- PendingCrosslinking Multispecific AntibodiesUSPTOApplication 18868692
- PendingSelf-immolative Linkers And Conjugates ThereofUSPTOApplication 63719829
- PendingCrosslinking AntibodiesUSPTOApplication 18723031
Show all 10 patent records
- Crosslinking Multispecific AntibodiesNov 20, 2025 · Application 18868692Pending
- Self-immolative Linkers And Conjugates ThereofApplication 63719829Pending
- Crosslinking AntibodiesApplication 18723031Pending
- Crosslinking Multispecific AntibodiesApplication PCTUS2023067512Pending
- Crosslinking AntibodiesApplication PCTUS2022082277Pending
- Crosslinking Single Domain AntibodiesApplication 63388072Pending
- Crosslinking Multispecific AntibodiesApplication 63346798Pending
- Crosslinking Multispecific AntibodiesApplication 63346799Pending
- Self-immolative Linkers And Conjugates ThereofApplication PCTUS2025055190Pending
- Crosslinking Single Domain AntibodiesApplication 63293025Pending
Related companies, and why
- VasaMetrixSimilar federal contract value in Biotech · null in contracts
- Avana Health, Inc.Similar federal contract value in Biotech · null in contracts
- EIKONOKLASTES THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- PAINREFORM LTD.Similar federal contract value in Biotech · null in contracts
- Isterian Biotech, Inc.Similar federal contract value in Biotech · null in contracts
- Seneca Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .